William (Bill) S. Dalton, Ph.D., M.D.

Founder and Executive Chair of M2Gen

Dr. William (Bill) S. Dalton is Founder and Executive Chair. He is the former CEO of M2Gen (2012-2017) and past President, CEO & Center Director of Moffitt Cancer Center, an NCI-Designated Comprehensive Cancer Center (2002-2012). During his tenure as CEO of Moffitt, he led the development of the Total Cancer Care program and creation of the Health Research Informatics platform designed to follow patients throughout their lifetime. He holds several patents in the area of personalized medicine and computer networking. In 2014, Moffitt Cancer Center, in partnership with the James Cancer Center at the Ohio State University, founded the cancer center alliance called ORIEN, Oncology Research Information and Exchange Network, with the goal of accelerating cancer research discovery by sharing information and delivering hope through collaborative learning and partnerships.

Joseph R. Smith, CPA, CGMA

Senior Vice President, Chief Financial Officer of M2Gen

Joseph R. Smith, CPA, CGMA, currently serves as the Senior Vice President and Chief Financial Officer for M2Gen, a wholly owned for profit subsidiary of Moffitt Cancer Center. In this role, Joe is responsible for the financial, marketing and sales aspects of M2Gen and provides leadership for the day to day financial and operational aspects of the business. Prior to joining M2Gen Joe served as Chief Operating Officer and Chief Financial Officer for Bisk Education and also was the CFO, Secretary and Treasurer for a private then public dental practice management company. Joe started his career in public accounting at Deloitte, rose to the level of Partner and was in charge of the middle market practice in the Tampa, Florida office. He holds a BSBA in Accounting with Honors from University of Florida.

Odalys Capote

VP Chief Administrative Officer, M2Gen

Odalys Capote serves as the Vice President/Chief Administrative Officer for M2Gen overseeing human resources, compliance, Board relations and growth of the Oncology Research Information Exchange (ORIEN). Over her career in healthcare, Odalys has held positions as Chief of Staff and Compliance & Privacy Officer, and has prior experience in cost accounting/decision support system implementation, project management and consulting. While at M2Gen, she also held a leadership role in the creation and operationalization of the Oncology Research Information Exchange Network (ORIEN) and the novel ORIEN Clinical Trials Network. She holds a Bachelor’s degree in Marketing from the University of South Florida School of Business.

Judy Barkal

Vice President and Chief Technology / Medical Informatics Officer, M2Gen

Judy Barkal currently serves as the Vice President and Chief Technology / Medical Informatics Officer at M2Gen. She brings deep experience in strategy, innovation and complex business and technology transformation. Judy’s most recent role was Head of Information Strategy and Innovation at Knight Cancer Institute, Oregon Health and Science University. At OHSU, Judy established a cancer informatics strategic roadmap and, as PI, led the creation of a clinical data repository integrated with genomics data to serve multiple cancer researchers and programs. Judy was previously a Partner at IBM, Global Business Services where she led complex business and technology transformations globally in financial services, healthcare, energy, and retail. Prior to IBM, Judy specialized in clusters and high performance computing at Sequent Computer Systems. In her early career, she developed safety-critical, real-time flight control systems at Rockwell Collins.

Stan Micek

Vice President and Chief Commercial Officer, M2Gen

Stan brings to M2Gen significant life sciences experience, including leadership roles within multiple aspects of the branded and generic pharmaceutical product value chain, new business ventures and negotiation of several, large corporate transactions.

Prior to joining M2Gen, Stan served as the Director, Oncology Commercialization at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). From 2014 to 2016, Stan was the Director of Licensing for The Ohio State University’s (OSU) Technology Commercialization Office. Prior to joining OSU, Stan held executive roles within two mid-sized pharmaceutical companies (Xanodyne Pharmaceuticals and AAIPharma) leading their corporate/ business development functions, specifically in- and out- licensing, acquisitions and divestitures.

For over 19 years at Abbott Laboratories he held positions of increasing responsibility in several functional areas, including national account sales, marketing, business development and licensing, engineering and international manufacturing/ operations.

Stan earned his B.Sc. in Chemical Engineering from the Illinois Institute of Technology in Chicago and his MBA in Marketing and International Management from Northwestern University’s Kellogg Graduate School of Management in Evanston, IL.

Oliver Hampton, Ph.D.

Vice President, Bioinformatics and Biostatistics

Oliver Hampton, PhD, currently serves as the VP of Bioinformatics and Biostatistics for M2Gen. Oliver leads the bioinformatics team and is building the biostatistics team to support the Avatar project, as well as collaborative projects between M2Gen, Pharma and ORIEN partners. Oliver comes to M2Gen with great expertise in Next-Generation-Sequencing, having led the Platform Informatics team, Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center. Prior to that, Oliver was an Assistant Professor at Baylor College of Medicine.